" class="no-js "lang="en-US"> Dan Calvo - Medtech Alert
Tuesday, April 16, 2024

Breaking News

Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program Captivate Bio and EverCell Bio partner on Human Cell Modeling Services for Cell and Gene Therapy Markets Applied StemCell Partners with CIRM to Provide Clinical-Grade iPSCs and Access to Its Proprietary Gene Editing Technologies Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors
Dan Calvo

Dan Calvo

About Dan Calvo

Related Story

Appointments

 seqWell Appoints Dr Amy Liao to Board of Directors | Pharmtech Focus

seqWell Appoints Dr Amy Liao to Board of Directors

June 15 2022

seqWell, a global provider of genomic library workflow solutions including the plexWell™ next-generation sequencing (NGS) multiplexing technology, […]

Industry News

 seqWell’s plexWell Technology Selected by California Conservation Genomics Project for Conservation Genomics Research | Pharmtech Focus

seqWell’s plexWell Technology Selected by California Conservation Genomics Project for Conservation Genomics Research

May 10 2022

seqWell, a global provider of next-generation sequencing (NGS) library technologies based on its proprietary plexWell™ […]

Industry News

 Codexis and seqWell Announce Strategic Investment and Partnership Initiation | Pharmtech Focus

Codexis and seqWell Announce Strategic Investment and Partnership Initiation

April 25 2022

Codexis, Inc. (Nasdaq: CDXS) and seqWell, Inc. today announced the initiation of a strategic partnership […]

Appointments

 seqWell Appoints New Commercial Team

seqWell Appoints New Commercial Team, Led by Chief Commercial Officer Steve Smith

October 5 2021

seqWell, a global provider of next-generation sequencing (NGS) library technologies based on its proprietary plexWell™ multiplexing […]